There were non-significant differences at entry between both groups for sex (two men; four women, mean age 24, range 21-27 years), duration of disease (13, range 2-24 months), EDSS (3-25, range 2-0-5 0), and number of Gd enhancing lesions per patient (total 58).
Side effects were not seen in any patient. Two patients in the IVMP group had improved by at least one point in the EDSS at the 10th day and one did not show any changes; in the IVIg group two patients remained stable and one deteriorated 3 0 points after the third day, then IVMP was initiated.
By the third day, nine lesions no longer enhanced in the IVMP group, whereas four new Gd enhancing lesions were noted in the IVIg treated patients (mean change from basal values: 32% decrease in the number of enhancing lesions in the IVMP group v 10% increase in the IVIg group; P = 0-009, Welch's t test). These differences were also obvious at the 10th day (80 v 30% decrease respectively) although they did not reach significance because only two patients were studied at this time in the IVIg group.
Damage to the blood-brain barrier seems to be an important early event in the development of focal demyelination in multiple sclerosis; therefore, rapid normalisation of the blood-brain barrier could be of critical importance in inhibiting early demyelination. Impairment of the blood-brain barrier in multiple sclerosis lesions can now be readily detected and safely monitored by Gd-DTP enhanced-MRI.4 High dose IVMP rapidly suppresses Gd-DTP enhancement in acute demyelinating lesions and this correlates well with clinical improvement. 5 The results of the present study suggest that IVIg does not rectify impairment of the blood-brain barrier during an exacerbation of multiple sclerosis and therefore it should not be considered as an alternative to standard steroid treatment for relapses in multiple sclerosis. However, the number of patients is too small and larger studies would be necessary to reach definite conclusions; furthermore, due to the short period of study, some beneficial effects of IVIg on other steps of myelin damage cannot be excluded. The clinical worsening in one patient could merely represent the natural history of exacerbation of multiple sclerosis, and may not necessarily be related to IVIg infusion. Over the next 24 hours her conscious level deteriorated to a Glasgow coma scale score of 9. She developed a sinus bradycardia of 45/min with a blood pressure of 80/50 mm Hg. Her oral temperature was 35 5°C and her rectal temperature was 29°C. She was appropriately dressed for the ambient air temperature of 18°C. Her skin did not feel abnormally cool and there was no shivering. General examination disclosed a few coarse crepitations scattered throughout both lungs. There was no meningism. The pupils were constricted and the corneal reflexes depressed. The jaw was tightly clenched. There was a spastic tetraparesis with extensor plantars but the reflexes were now depressed.
Neuroinvestigaci6-Esclerosi Multiple
Haematological investigations showed a picture consistent with mild disseminated intravascular coagulation (platelets 79; activated partial thromboplastin time 45 s (control 32 s); TCT 17 s (control 14 s); INR 1 -0). Electrolytes and glucose were normal but the amylase concentration was slightly raised at 321 IU/l, suggesting mild pancreatitis. An ECG showed widespread J waves, the presence of which had led to the taking of the core temperature and thus the diagnosis. Chest radiography showed mild bilateral basal shadowing. Blood and urine toxin screens were negative.
The patient was slowly rewarmed and treated with intravenous atropine and antibiotics. However, she developed recurrent dysrhythmias, predominantly bradycardic in nature, and bronchopneumonia. She died three days later.
Postmortem examination confirmed the presence of bronchopneumonia and pancreatitis. The brain and spinal cord contained numerous plaques of demyelination typical of chronic multiple sclerosis. There was a large plaque involving the hypothalamus (figure). This had the grey, translucent appearance typical of a mature gliotic plaque. However, at the microscopic level there was evidence of current activity in a 5% -3.
Hypothalamus. Solochrome The physiological response to hypothermia is controlled by the hypothalamus, involving peripheral vasoconstriction and shivering. In hypothalamic hypothermia these systems fail with loss of reactive peripheral vasoconstriction to reduce heat loss and loss of the shivering response to produce heat. It is the failure of these systems that contributes to the hypothermia and also produces diagnostic difficulty, with the patient feeling warm to the touch and not shivering. The ECG showing the pathognomonic J waves, with absence of shiver waves mirrored the hypothalamic cause of the hypothermia. This is the first description of hypothermia in a patient with multiple sclerosis with a proved hypothalamic plaque and no other identifiable cause for hypothermia.
We thank David Hughes for the preparation of the histopathological photographs. October the patient was admitted to hospital. The myoclonic jerks had reinforced, occurring sometimes in bursts, occasionally involving the neck and the shoulders but never the face. The patient was agitated and exhausted, and cried on account of the continuous distressing pains. She was free of headache and fever. Walking was difficult, although she felt better when standing. She had a mild motor deficit in the proximal part of the lower limbs, patellar tendon reflexes abolished on the right, diminished on the left, normal ankle reflexes, plantar reflexes flexor, and axial muscles and neck were not rigid. Results from routine laboratory investigations were normal. Ketoprofene, haloperidol, clorazepate, and then tiaprid, paracetamol, and buprenorphine were tried with negligible relief. On 19 October, she was transferred to the intensive care unit. The painful jerks were flexor, simultaneous in all the muscles, and spontaneous or induced consistently by flexion of the neck, without involvement of the face and superior limbs. The intervals between the jerks became so short that the paroxyms gave the impression of being attacks of sustained truncal flexion. An EEG during jerking was unremarkable. Finally, the patient was anaesthetised and ventilated artificially. The treatment was propofol, fentanyl, and muscle relaxant pancuronium. Ceftriaxone (2 g intravenously daily) was given for 14 days. A 63 year old right handed man with a previous history of hypertension was admitted to the hospital with acute right hemiparesis. On admission, his visual field examination showed a right homonymous hemianopia. There was also a right inferior facial palsy and a right hemiparesis without sensory involvement. The right homonymous hemianopsia disappeared on the third day. On the fourth day, he complained that the doctor's left cheek seemed to have been scraped, that the doctor's left hand seemed tortuous, and that some of the fingers of the hand seemed to be missing. He drew a picture of what he saw (figlA). Visual field examination by confrontation was immediately performed but no abnormalities were found, later confirmed by using Goldmann's perimeter. On the next day, he complained, "The right half of the curtain in front of me suddenly transforms into an animal's face. It rotates there for a while and finally flows to the right, and then disappears. At the next moment, another face springs up at the very portion and. . ." He then drew a picture to illustrate his experience ( fig 1B) . These phenomena lasted three to four days and then disappeared. One month later, he was able to walk without assistance and was discharged from hospital.
S EDWARDS G LENNOX
The laboratory analysis of blood and urine was within the normal range. Cranial CT on admission showed a left putaminal haemorrhage without ventricular extension
